DXCM
DexCom, Inc.
112.03
USD
This page is just a preview of the data found in TrendSpider’s full version
DexCom, Inc. stock is up 31.94% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.63% of the previous 18 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 24 Nov 15:15 | 19 Jan, 2024 | 112.50 | 1277 | ||
| 24 Nov 15:46 | 21 Jun, 2024 | 135.00 | 293 | ||
| 27 Nov 16:00 | 19 Jan, 2024 | 120.00 | 32 | ||
| 27 Nov 17:46 | 19 Jan, 2024 | 125.00 | 432 | ||
| 27 Nov 17:59 | 15 Dec, 2023 | 105.00 | 1207 | ||
| 27 Nov 19:51 | 19 Jan, 2024 | 115.00 | 1639 | ||
| 28 Nov 15:29 | 21 Jun, 2024 | 90.00 | 196 | ||
| 28 Nov 16:25 | 15 Dec, 2023 | 115.00 | 2210 | ||
| 28 Nov 16:31 | 16 Feb, 2024 | 115.00 | 183 | ||
| 28 Nov 19:33 | 19 Jan, 2024 | 112.50 | 332 |
DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system.
